H7N9感染の治療中にオセルタミビル耐性が生じる
Alan J Hay1, Frederick G Hayden
1Virology Division, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK. ahay@nimr.mrc.ac.uk
Lancet (London, England)
|July 2, 2013
まとめ
No abstract available in PubMed .
さらに関連する動画
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
18.9K
09:04Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
11.9K
